Vincristine
| Use attributes for filter ! | |
| Formula | C46H56N4O10 |
|---|---|
| Molar mass | 824. 958 g/mol |
| CAS ID | 57-22-7 |
| Excretion | Faeces (70–80%), urine (10–20%) |
| Trade name | Oncovin, Vincasar, others |
| Elimination half-life | 19 to 155 hours (mean: 85 hours) |
| Metabolism | CYP3A4 |
| CYP3A5 | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951509 |
About Vincristine
Vincristine, also known as leurocristine and marketed under the brandname Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others.